Generated: December 14, 2017
DrugPatentWatch Database Preview
Details for Patent: 6,453,795
« Back to Dashboard
Which drugs does patent 6,453,795 protect, and when does it expire?
Summary for Patent: 6,453,795
|Title:|| Locking mechanism for a spring-actuated device|
|Abstract:||A spring-actuated output drive device is used for example in medical aerosol therapy for a miniaturised high-pressure producing device for atomising a small dose of a liquid medicament. A locking-stressing-mechanism for such an output d rive device is to be stressed with the application of a relatively small amount of force and is to be released with one hand and is to operate reliably over a prolonged period of time. The locking-stressing-mechanism comprises a force step-up transmission, for example a screw thrust transmission for stressing the spring, an annularly arranged locking member with engaging locking surfaces, two abutments for limiting the travel of the spring and a release button. It is compact, economical to produce, easy to assemble and comprises components with a low rate of wear. It can be reliably and easily handled by unskilled persons, even when high spring forces are involved. A medicament to be atomised can thus be metered with a very high degree of accuracy.|
|Inventor(s):|| Eicher; Joachim (Dortmund, DE), Schyra; Michael (Wulfrath, DE), Forster; Richard (Fensterbach, DE) |
|Assignee:|| Boehringer Ingelheim International GmbH (DE) |
Patent Claim Types:|
see list of patent claims
||Patented / Exclusive Use
|Boehringer Ingelheim||COMBIVENT RESPIMAT||albuterol sulfate; ipratropium bromide||SPRAY, METERED;INHALATION||021747-001||Oct 7, 2011||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-002||Sep 15, 2015||RX||Yes||No||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||STIOLTO RESPIMAT||olodaterol hydrochloride; tiotropium bromide||SPRAY, METERED;INHALATION||206756-001||May 21, 2015||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||STRIVERDI RESPIMAT||olodaterol hydrochloride||SPRAY, METERED;INHALATION||203108-001||Jul 31, 2014||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-001||Sep 24, 2014||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Foreign Priority and PCT Information for Patent: 6,453,795
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Germany||195 45 226||Dec 05, 1995|
|Germany||195 45 226||Dec 5, 1995|
|PCT Filed||December 05, 1996||PCT Application Number:||PCT/EP96/05607|
|PCT Publication Date:||June 12, 1997||PCT Publication Number:||
International Patent Family for Patent: 6,453,795
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.